Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data

Title
Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data
Authors
Keywords
Bone mineral density, Fracture risk, Monthly, Osteoporosis, Risedronate
Journal
OSTEOPOROSIS INTERNATIONAL
Volume 24, Issue 1, Pages 293-299
Publisher
Springer Nature
Online
2012-06-29
DOI
10.1007/s00198-012-2056-0

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now